EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access

Evaluation of the Contrast-Enhanced Ultrasound Nonradiation Treatment Response Assessment LI-RADS v2024 Using Data From a Multi-Center Transarterial Chemoembolization Study

Cristina M Kuon Yeng Escalante, Tania Siu Xiao, Rohit U Nagaraj, Esika Savsani, Amr Mohammed, Joy Li, Andrej Lyshchik, Ji-Bin Liu, Corinne E Wessner, Aylin Tahmasebi, Michael C Soulen, Yuko Kono und 1 weitere

Academic Radiology · 2024

DOI: 10.1016/j.acra.2024.06.005 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Academic Radiology, 2024. Verfasst von Cristina M Kuon Yeng Escalante und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Contrast Media. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE AND OBJECTIVE: Hepatocellular carcinoma (HCC) locoregional treatment response is commonly evaluated using the Modified Response Evaluation Criteria in Solid Tumors and the American College of Radiology (ACR) Liver Reporting and Data System (LI-RADS) Treatment Response Assessment (TRA) for MRI/CT. This study aims to evaluate the diagnostic performance of the new ACR contrast-enhanced ultrasound (CEUS) Nonradiation TRA LI-RADS v2024 in HCC treated with transarterial chemoembolization (TACE). MATERIALS AND METHODS: This retrospective observational study included 87 patients treated with TACE from a previously reported cohort. At 15- and 30-days post-treatment, 68 and 72 HCC lesions were evaluated. Three blinded radiologists with different levels of CEUS experience interpreted the images independently. According to CEUS Nonradiation TRA LI-RADSv2024, both intralesional and perilesional tumor viability were evaluated and final TRA categories were as follows: TR-Nonviable, TR-Equivocal, and TR-Viable. The reference standard used was a composite of histology and imaging. RESULTS: 140 HCC lesions were analyzed. At 15 days post-treatment, the sensitivity (SN), specificity (SP), positive predictive value (PPV), negative predictive value (NPV), and accuracy of TR-Viable classification ranged from 72.5-94.3%, 72.2-86.4%, 86.8-91.4%, 65.6-86.7%, 76.9-86.8%, respectively. At 30 days post-treatment, the SN, PPV, and NPV of TR-Viable classification decreased, ranging from 65.9-84.2%, 85.7-90.6%, and 59.5-73.9%, respectively, while the SP increased, ranging from 80.0-88.0%. Kappa values ranged from 0.557-0.730, indicating moderate to substantial agreement. CONCLUSION: CEUS Nonradiation TRA LI-RADS is a reliable tool for the detection of viable tumors in lesions treated with TACE and demonstrates reproducibility across readers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularChemoembolization, TherapeuticContrast MediaUltrasonographySensitivity and SpecificityHumansMaleFemaleRetrospective StudiesMiddle AgedAgedTreatment OutcomeAdultAged, 80 and overResponse Evaluation Criteria in Solid TumorsReproducibility of Results

Stichwörter der Autor:innen

CEUSContrast-enhanced ultrasoundHepatocellular CarcinomaLI-RADSTransarterial chemoembolizationTreatment Response Algorithm

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
  • Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Medicine, Gastroenterology and Hepatology, University of California, San Diego, California, USA.
  • Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA. Electronic address: John.Eisenbrey@jefferson.edu.

Förderung

  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Kuon Yeng Escalante, C. M., Siu Xiao, T., Nagaraj, R. U., Savsani, E., Mohammed, A., Li, J., Lyshchik, A., Liu, J. B., Wessner, C. E., Tahmasebi, A., Soulen, M. C., Kono, Y., & Eisenbrey, J. R. (2024). Evaluation of the Contrast-Enhanced Ultrasound Nonradiation Treatment Response Assessment LI-RADS v2024 Using Data From a Multi-Center Transarterial Chemoembolization Study. Academic Radiology. https://doi.org/10.1016/j.acra.2024.06.005

Vancouver

Kuon Yeng Escalante CM, Siu Xiao T, Nagaraj RU, Savsani E, Mohammed A, Li J, et al. Evaluation of the Contrast-Enhanced Ultrasound Nonradiation Treatment Response Assessment LI-RADS v2024 Using Data From a Multi-Center Transarterial Chemoembolization Study. Academic Radiology. 2024. doi:10.1016/j.acra.2024.06.005

BibTeX
@article{KuonYengEscalante2024,
  author = {Kuon Yeng Escalante, Cristina M and Siu Xiao, Tania and Nagaraj, Rohit U and Savsani, Esika and Mohammed, Amr and Li, Joy and Lyshchik, Andrej and Liu, Ji-Bin and Wessner, Corinne E and Tahmasebi, Aylin and Soulen, Michael C and Kono, Yuko and Eisenbrey, John R},
  title = {Evaluation of the Contrast-Enhanced Ultrasound Nonradiation Treatment Response Assessment LI-RADS v2024 Using Data From a Multi-Center Transarterial Chemoembolization Study},
  journal = {Academic Radiology},
  year = {2024},
  doi = {10.1016/j.acra.2024.06.005}
}
Kostenlos starten →